News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News RentRedi Unveils First Ever Money-Back Guarantee, Raising the Bar for Landlord Confidence News Orezone Reports Q3-2025 Production and Hard Rock Expansion Update News Rumble and Perplexity Introduce Subscription Bundle for Rumble Premium and Perplexity Pro News Oli Launches Canada’s First All-in-One Healthcare Hiring Platform News Citizens Bank of West Virginia Signs With Point Predictive to Deploy AutoPass™ and DealerCheck™ for Enhanced Fraud Prevention News Copyleaks Recognized as the Most Accurate AI Detector
